Loading…

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness

A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adeno...

Full description

Saved in:
Bibliographic Details
Published in:Virchows Archiv : an international journal of pathology 2005-06, Vol.446 (6), p.589-595
Main Authors: TROVISCO, Vitor, SOARES, Paula, MAGALHAES, Joao, ABROSIMOV, Alexander, CAMESELLE-TEIJEIRO, José, SOBRINHO-SIMOES, Manuel, PRETO, Ana, VIEIRA DE CASTRO, Ines, LIMA, Jorge, CASTRO, Patricia, MAXIMO, Valdemar, BOTELHO, Tiago, MOREIRA, Severina, MARGARIDA MEIRELES, Ana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3
cites cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3
container_end_page 595
container_issue 6
container_start_page 589
container_title Virchows Archiv : an international journal of pathology
container_volume 446
creator TROVISCO, Vitor
SOARES, Paula
MAGALHAES, Joao
ABROSIMOV, Alexander
CAMESELLE-TEIJEIRO, José
SOBRINHO-SIMOES, Manuel
PRETO, Ana
VIEIRA DE CASTRO, Ines
LIMA, Jorge
CASTRO, Patricia
MAXIMO, Valdemar
BOTELHO, Tiago
MOREIRA, Severina
MARGARIDA MEIRELES, Ana
description A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P
doi_str_mv 10.1007/s00428-005-1236-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67952192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67952192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</originalsourceid><addsrcrecordid>eNpdkd2KFDEQhYMo7jj6AN5IENSr1spPZzqXu4urwoIg63WoTqd3snQnbZJemXfxYc0ygwteVQhfnTpVh5DXDD4ygN2nDCB51wC0DeNCNfCEbJgUvOECdk_JBrRsGyXY7oy8yPkOgLOOqefkjLUauOzUhvy5OSyOYhjoktw9Ti5YR-NIL36cX9F5LVh8DJlictROMbvpQDHnaD0WN9DfvuzpgoufJkwHWvaHFP1ALSbrQ5yR7n0usfwbUdVcKPkDxVtH-7XQEMtRpKxzXFP9v00uZ3_vQi0vybMRp-xeneqW_Lz6fHP5tbn-_uXb5fl1Y0WrSoN1LTmogbm-syBB6h65FMxhJ5juWm3HTikYQWvNuezboZWqPpEpiYPtxZa8P-ouKf5aXS5m9tm6ulRwcc1G7XTLmeYVfPsfeFddh-rNdBx2gss6d0vYEbIp5pzcaJbk53ofw8A85GaOuZmam3nIzUDteXMSXvvZDY8dp6Aq8O4EYLY4jQmD9fmRU5WrLsVflKmiPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>820732424</pqid></control><display><type>article</type><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><source>Springer Nature</source><creator>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</creator><creatorcontrib>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</creatorcontrib><description>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P&lt;0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-005-1236-0</identifier><identifier>PMID: 15902486</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adenocarcinoma - genetics ; Adult ; Age Factors ; Carcinoma, Papillary - genetics ; Carcinoma, Papillary, Follicular - genetics ; DNA Mutational Analysis ; Humans ; Male ; Middle Aged ; Mutation ; Polymerase Chain Reaction ; Polymorphism, Single-Stranded Conformational ; Proto-Oncogene Proteins B-raf - genetics ; Sex Factors ; Thyroid ; Thyroid Neoplasms - genetics ; Tumors</subject><ispartof>Virchows Archiv : an international journal of pathology, 2005-06, Vol.446 (6), p.589-595</ispartof><rights>2005 INIST-CNRS</rights><rights>Springer-Verlag 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</citedby><cites>FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16902795$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15902486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TROVISCO, Vitor</creatorcontrib><creatorcontrib>SOARES, Paula</creatorcontrib><creatorcontrib>MAGALHAES, Joao</creatorcontrib><creatorcontrib>ABROSIMOV, Alexander</creatorcontrib><creatorcontrib>CAMESELLE-TEIJEIRO, José</creatorcontrib><creatorcontrib>SOBRINHO-SIMOES, Manuel</creatorcontrib><creatorcontrib>PRETO, Ana</creatorcontrib><creatorcontrib>VIEIRA DE CASTRO, Ines</creatorcontrib><creatorcontrib>LIMA, Jorge</creatorcontrib><creatorcontrib>CASTRO, Patricia</creatorcontrib><creatorcontrib>MAXIMO, Valdemar</creatorcontrib><creatorcontrib>BOTELHO, Tiago</creatorcontrib><creatorcontrib>MOREIRA, Severina</creatorcontrib><creatorcontrib>MARGARIDA MEIRELES, Ana</creatorcontrib><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P&lt;0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</description><subject>Adenocarcinoma - genetics</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Carcinoma, Papillary - genetics</subject><subject>Carcinoma, Papillary, Follicular - genetics</subject><subject>DNA Mutational Analysis</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Single-Stranded Conformational</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Sex Factors</subject><subject>Thyroid</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Tumors</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpdkd2KFDEQhYMo7jj6AN5IENSr1spPZzqXu4urwoIg63WoTqd3snQnbZJemXfxYc0ygwteVQhfnTpVh5DXDD4ygN2nDCB51wC0DeNCNfCEbJgUvOECdk_JBrRsGyXY7oy8yPkOgLOOqefkjLUauOzUhvy5OSyOYhjoktw9Ti5YR-NIL36cX9F5LVh8DJlictROMbvpQDHnaD0WN9DfvuzpgoufJkwHWvaHFP1ALSbrQ5yR7n0usfwbUdVcKPkDxVtH-7XQEMtRpKxzXFP9v00uZ3_vQi0vybMRp-xeneqW_Lz6fHP5tbn-_uXb5fl1Y0WrSoN1LTmogbm-syBB6h65FMxhJ5juWm3HTikYQWvNuezboZWqPpEpiYPtxZa8P-ouKf5aXS5m9tm6ulRwcc1G7XTLmeYVfPsfeFddh-rNdBx2gss6d0vYEbIp5pzcaJbk53ofw8A85GaOuZmam3nIzUDteXMSXvvZDY8dp6Aq8O4EYLY4jQmD9fmRU5WrLsVflKmiPA</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>TROVISCO, Vitor</creator><creator>SOARES, Paula</creator><creator>MAGALHAES, Joao</creator><creator>ABROSIMOV, Alexander</creator><creator>CAMESELLE-TEIJEIRO, José</creator><creator>SOBRINHO-SIMOES, Manuel</creator><creator>PRETO, Ana</creator><creator>VIEIRA DE CASTRO, Ines</creator><creator>LIMA, Jorge</creator><creator>CASTRO, Patricia</creator><creator>MAXIMO, Valdemar</creator><creator>BOTELHO, Tiago</creator><creator>MOREIRA, Severina</creator><creator>MARGARIDA MEIRELES, Ana</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</title><author>TROVISCO, Vitor ; SOARES, Paula ; MAGALHAES, Joao ; ABROSIMOV, Alexander ; CAMESELLE-TEIJEIRO, José ; SOBRINHO-SIMOES, Manuel ; PRETO, Ana ; VIEIRA DE CASTRO, Ines ; LIMA, Jorge ; CASTRO, Patricia ; MAXIMO, Valdemar ; BOTELHO, Tiago ; MOREIRA, Severina ; MARGARIDA MEIRELES, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - genetics</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Carcinoma, Papillary - genetics</topic><topic>Carcinoma, Papillary, Follicular - genetics</topic><topic>DNA Mutational Analysis</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Single-Stranded Conformational</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Sex Factors</topic><topic>Thyroid</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TROVISCO, Vitor</creatorcontrib><creatorcontrib>SOARES, Paula</creatorcontrib><creatorcontrib>MAGALHAES, Joao</creatorcontrib><creatorcontrib>ABROSIMOV, Alexander</creatorcontrib><creatorcontrib>CAMESELLE-TEIJEIRO, José</creatorcontrib><creatorcontrib>SOBRINHO-SIMOES, Manuel</creatorcontrib><creatorcontrib>PRETO, Ana</creatorcontrib><creatorcontrib>VIEIRA DE CASTRO, Ines</creatorcontrib><creatorcontrib>LIMA, Jorge</creatorcontrib><creatorcontrib>CASTRO, Patricia</creatorcontrib><creatorcontrib>MAXIMO, Valdemar</creatorcontrib><creatorcontrib>BOTELHO, Tiago</creatorcontrib><creatorcontrib>MOREIRA, Severina</creatorcontrib><creatorcontrib>MARGARIDA MEIRELES, Ana</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TROVISCO, Vitor</au><au>SOARES, Paula</au><au>MAGALHAES, Joao</au><au>ABROSIMOV, Alexander</au><au>CAMESELLE-TEIJEIRO, José</au><au>SOBRINHO-SIMOES, Manuel</au><au>PRETO, Ana</au><au>VIEIRA DE CASTRO, Ines</au><au>LIMA, Jorge</au><au>CASTRO, Patricia</au><au>MAXIMO, Valdemar</au><au>BOTELHO, Tiago</au><au>MOREIRA, Severina</au><au>MARGARIDA MEIRELES, Ana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><addtitle>Virchows Arch</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>446</volume><issue>6</issue><spage>589</spage><epage>595</epage><pages>589-595</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>A high prevalence of the BRAF(V600E) somatic mutation was recently reported in several series of papillary thyroid carcinomas (PTC). This mutation appears to be particularly prevalent in PTC with a predominantly papillary architecture. Another BRAF mutation (K601E) was detected in a follicular adenoma and in some cases of the follicular variant of PTC. The few studies on record provided controversial data on the relationship between the occurrence of BRAF mutations and clinicopathologic parameters such as gender, age and tumour staging. In an attempt to clarify such controversies we decided to enlarge our previous series to 315 tumours or tumour-like lesions diagnosed in 280 patients, including a thorough analysis of several clinicopathologic features. The BRAF(V600E) mutation was exclusively detected in PTC with a papillary or mixed follicular/papillary architecture both of the conventional type (46%) and of other histotypes, such as microcarcinoma (43%), Warthin-like PTC (75%) and oncocytic variant of PTC (55%). The BRAF(K601E) mutation was detected in four of the 54 cases of the follicular variant of PTC (7%). The mean age of patients with conventional PTC harbouring BRAF(V600E) (46.7 years) was significantly higher (P&lt;0.0001) than that of patients with conventional PTC without BRAF(V600E) (29.5 years). The BRAF (BRAF(V600E)) mutated PTC did not exhibit signs of higher aggressiveness (size, vascular invasion, extra-thyroid extension and nodal metastasis) and were in fact less often multicentric than PTC without the mutation.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>15902486</pmid><doi>10.1007/s00428-005-1236-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0945-6317
ispartof Virchows Archiv : an international journal of pathology, 2005-06, Vol.446 (6), p.589-595
issn 0945-6317
1432-2307
language eng
recordid cdi_proquest_miscellaneous_67952192
source Springer Nature
subjects Adenocarcinoma - genetics
Adult
Age Factors
Carcinoma, Papillary - genetics
Carcinoma, Papillary, Follicular - genetics
DNA Mutational Analysis
Humans
Male
Middle Aged
Mutation
Polymerase Chain Reaction
Polymorphism, Single-Stranded Conformational
Proto-Oncogene Proteins B-raf - genetics
Sex Factors
Thyroid
Thyroid Neoplasms - genetics
Tumors
title Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A29%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20and%20prevalence%20of%20BRAF%20mutations%20are%20closely%20associated%20with%20papillary%20thyroid%20carcinoma%20histotype%20and%20patients'%20age%20but%20not%20with%20tumour%20aggressiveness&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=TROVISCO,%20Vitor&rft.date=2005-06-01&rft.volume=446&rft.issue=6&rft.spage=589&rft.epage=595&rft.pages=589-595&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-005-1236-0&rft_dat=%3Cproquest_cross%3E67952192%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-a2184d6d1eb8c04049ba2431ea8319859cf8660f0999224b5d546992a164adcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=820732424&rft_id=info:pmid/15902486&rfr_iscdi=true